162 related articles for article (PubMed ID: 2807528)
1. Altered in vivo activity of liposome-incorporated lipopolysaccharide and lipid A.
Dijkstra J; Mellors JW; Ryan JL
Infect Immun; 1989 Nov; 57(11):3357-63. PubMed ID: 2807528
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the biological activity of bacterial endotoxin by incorporation into liposomes.
Dijkstra J; Mellors JW; Ryan JL; Szoka FC
J Immunol; 1987 Apr; 138(8):2663-70. PubMed ID: 3494081
[TBL] [Abstract][Full Text] [Related]
3. Incorporation of LPS in liposomes diminishes its ability to induce tumoricidal activity and tumor necrosis factor secretion in murine macrophages.
Dijkstra J; Larrick JW; Ryan JL; Szoka FC
J Leukoc Biol; 1988 May; 43(5):436-44. PubMed ID: 3131472
[TBL] [Abstract][Full Text] [Related]
4. A procedure for the efficient incorporation of wild-type lipopolysaccharide into liposomes for use in immunological studies.
Dijkstra J; Ryan JL; Szoka FC
J Immunol Methods; 1988 Nov; 114(1-2):197-205. PubMed ID: 3263442
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of liposome-incorporation on liver macrophage activating potencies of rough lipopolysaccharide, lipid A, and muramyl dipeptide. Differences in susceptibility to lysosomal enzymes.
Daemen T; Veninga A; Dijkstra J; Scherphof G
J Immunol; 1989 Apr; 142(7):2469-74. PubMed ID: 2926140
[TBL] [Abstract][Full Text] [Related]
6. FITC-labeled lipopolysaccharide: use as a probe for liposomal membrane incorporation studies.
Trubetskoy VS; Koshkina NV; Omel'yanenko VG; L'vov VL; Dmitriev BA; Petrov AB; Torchilin VP
FEBS Lett; 1990 Aug; 269(1):79-82. PubMed ID: 2117560
[TBL] [Abstract][Full Text] [Related]
7. Toxicity and immunogenicity of Neisseria meningitidis lipopolysaccharide incorporated into liposomes.
Petrov AB; Semenov BF; Vartanyan YP; Zakirov MM; Torchilin VP; Trubetskoy VS; Koshkina NV; L'Vov VL; Verner IK; Lopyrev IV
Infect Immun; 1992 Sep; 60(9):3897-903. PubMed ID: 1500196
[TBL] [Abstract][Full Text] [Related]
8. Activation of murine lymphocytes by lipopolysaccharide incorporated in fusogenic, reconstituted influenza virus envelopes (virosomes).
Dijkstra J; Bron R; Wilschut J; de Haan A; Ryan JL
J Immunol; 1996 Aug; 157(3):1028-36. PubMed ID: 8757606
[TBL] [Abstract][Full Text] [Related]
9. Early-phase endotoxin tolerance: induction by a detoxified lipid A derivative, monophosphoryl lipid A.
Madonna GS; Peterson JE; Ribi EE; Vogel SN
Infect Immun; 1986 Apr; 52(1):6-11. PubMed ID: 3514464
[TBL] [Abstract][Full Text] [Related]
10. Incorporation of recombinant gamma interferon into liposomes enhances its ability to induce peritoneal macrophage antitoxoplasma activity.
Mellors JW; Debs RJ; Ryan JL
Infect Immun; 1989 Jan; 57(1):132-7. PubMed ID: 2491832
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies to salmonella lipopolysaccharide: functional analysis of anti-lipid A antibodies.
Ward DC; Michalek SM; McGhee JR
Clin Exp Immunol; 1988 Apr; 72(1):157-63. PubMed ID: 3293850
[TBL] [Abstract][Full Text] [Related]
12. Neutralization of Shwartzman-inducing activity by antibodies recognizing the Re core or lipid A structures of lipopolysaccharide from Salmonella minnesota R595 and Pseudomonas vesicularis JCM1477.
Mashimo J; Mizutani T; Mita A; Kasai N
Microbiol Immunol; 1991; 35(6):423-34. PubMed ID: 1921759
[TBL] [Abstract][Full Text] [Related]
13. Biological and serological characterization of Campylobacter jejuni lipopolysaccharides with deviating core and lipid A structures.
Moran AP
FEMS Immunol Med Microbiol; 1995 Apr; 11(2):121-30. PubMed ID: 7640672
[TBL] [Abstract][Full Text] [Related]
14. Salmonella-type heptaacylated lipid A is inactive and acts as an antagonist of lipopolysaccharide action on human line cells.
Tanamoto K; Azumi S
J Immunol; 2000 Mar; 164(6):3149-56. PubMed ID: 10706705
[TBL] [Abstract][Full Text] [Related]
15. Influence of hexadecylphosphocholine on the release of tumor necrosis factor and nitroxide from peritoneal macrophages in vitro.
Zeisig R; Rudolf M; Eue I; Arndt D
J Cancer Res Clin Oncol; 1995; 121(2):69-75. PubMed ID: 7883777
[TBL] [Abstract][Full Text] [Related]
16. Endotoxic properties of free lipid A from Porphyromonas gingivalis.
Tanamoto KI; Azumi S; Haishima Y; Kumada H; Umemoto T
Microbiology (Reading); 1997 Jan; 143 ( Pt 1)():63-71. PubMed ID: 9025279
[TBL] [Abstract][Full Text] [Related]
17. Cross-reactive murine monoclonal antibodies directed against the core/lipid A region of endotoxin inhibit production of tumor necrosis factor.
Mayoral JL; Dunn DL
J Surg Res; 1990 Oct; 49(4):287-92. PubMed ID: 1699085
[TBL] [Abstract][Full Text] [Related]
18. Multistep regulation mechanisms for tolerance induction to lipopolysaccharide lethality in the tumor-necrosis-factor-alpha-mediated pathway. Application of non-toxic monosaccharide lipid A analogues for elucidation of mechanisms.
Matsuura M; Kiso M; Hasegawa A; Nakano M
Eur J Biochem; 1994 Apr; 221(1):335-41. PubMed ID: 8168521
[TBL] [Abstract][Full Text] [Related]
19. Coincorporation of LpxL1 and PagL mutant lipopolysaccharides into liposomes with Neisseria meningitidis opacity protein: influence on endotoxic and adjuvant activity.
Arenas J; van Dijken H; Kuipers B; Hamstra HJ; Tommassen J; van der Ley P
Clin Vaccine Immunol; 2010 Apr; 17(4):487-95. PubMed ID: 20107001
[TBL] [Abstract][Full Text] [Related]
20. Antitumoral properties and reduced toxicity of LPS targeted to macrophages via normal or mannosylated liposomes.
Dumont S; Muller CD; Schuber F; Bartholeyns J
Anticancer Res; 1990; 10(1):155-60. PubMed ID: 2334121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
